Thursday, February 28, 2019

U.S. Senator Sanders urges FDA to allow older versions of $375,000 drug

U.S. Senator Bernie Sanders this week urged regulators to allow pharmacies and manufacturers to resume distributing unbranded, lower-cost versions of a drug used to treat a rare neuromuscular disorder, according to a letter provided by his office to Reuters.


from Reuters: Health News https://reut.rs/2NA3M1w

No comments:

Post a Comment